Human recombinant activated protein C vs placebo
Serious bleeding events in adult and paediatric patients (days 0 to 28) · patients with severe sepsis or septic shock
Human recombinant activated protein C probably leads to higher serious bleeding events in adult and paediatric patients (days 0 to… compared with placebo (moderate certainty).
1 finding from 1 review
- Human recombinant protein C for severe sepsis and septic shock in adult and paediatric patients 2012 · Cochrane Headline outcomes onlyRR 1.45 [1.08, 1.94]6 studies · 6767 participantsModerate